Enfusion, Inc.

Delisted

CIK 1868912fmd_04D1QM6R5350ZGRVQVNKZYY6C0Services · Services-Prepackaged SoftwareTemplate: Standard

Coverage: Jan 01, 2019 to Dec 31, 2024, 18 periods

Income Statement · Annual · Millions · USD
Line item	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Total revenues	59	80	112	150	175	202
Cost of revenue	17	21	32	47	58	65
Gross profit	42	58	80	103	117	137
Selling, general and administrative	24	46	202	98	85	104
Total operating expenses	28	52	356	115	105	131
Operating income	14	6	(276)	(12)	12	6
Interest expense	1	2	5	–	–	–
Other non-operating income (expense)	(1)	(2)	(6)	(0)	(0)	1
Income before taxes	13	4	(282)	(12)	11	7
Income tax expense	0	0	1	1	2	3
Net income from continuing operations	13	4	(282)	(13)	9	4
Net income	13	4	(158)	(8)	6	3
Net income to common shareholders	–	–	(188)	(9)	6	3